Medical Devices Roundtable Forum 2021

Paolo Silvestri, Clinical Affairs Director, Cardionovum

• The MDR roll-out so far: how are companies preparing?
• The impact of COVID-19 on MDR implementation in medical device companies
• MDR and Brexit: coping with evolving regulatory landscape in the UK
• Is IVD ready for IVDR?
• Are the notified bodies fully prepared?

MODERATOR:

Andrew Thompson, Director of Therapy Research and Analysis, Medical Devices, GlobalData

PANELLISTS:

John Shillingford, Director of Clinical Research, Afon Technology

Paolo Silvestri, Clinical Affairs Director, Cardionovum

Each table runs twice (11:00am and 12:00pm) on the same topic. Tables are exclusive, other vendors cannot attend. Minimum 10 participants for each table.

Attendees can select up to 2 roundtables.

1. The usage of real-world evidence for medical device trials – IQVIA MedTech
2. Is the UK still a destination of choice for clinical evaluation? – Sarah Cooper, Business Development Manager, NIHR
3. Clinical Evaluation and Post Market Clinical Follow-up under MDR – basis and practical cases – Qmed Consulting
4. Regulatory Evolution in Medical Device Development – Fiona Maini, Principal, Global Compliance and Strategy, Medidata
5. CERs under MDR – Common pitfalls and building adequate clinical evidence – Evnia
6. Outsourcing your medical device trials: managing the sponsor-vendor relationship – Lumis